Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma (Q35800541)
Jump to navigation
Jump to search
scientific article published on January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma |
scientific article published on January 2006 |
Statements
1 reference
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma (English)
1 reference
Michael D Prados
1 reference
Kathleen R Lamborn
1 reference
Susan Chang
1 reference
Eric Burton
1 reference
Nicholas Butowski
1 reference
Mary Malec
1 reference
Ami Kapadia
1 reference
Jane Rabbitt
1 reference
Margaretta S Page
1 reference
Ann Fedoroff
1 reference
Dong Xie
1 reference
Sean K Kelley
1 reference
Identifiers
1 reference